Using Healthcare Claims Data for Outcomes Research and Pharmacoeconomic Analyses Howard G. BirnbaumPierre Y. CremieuxLaura Venditti Current Opinion 22 September 2012 Pages: 1 - 8
The Pharmacoeconomics of Hormone Replacement Therapy David J. TorgersonDavid M. Reid Review Article 22 September 2012 Pages: 9 - 16
Benefit Valuation in Economic Evaluation of Cancer Therapies Jackie BrownMark Sculpher Review Article 22 September 2012 Pages: 17 - 31
Measuring Sensitivity in Pharmacoeconomic Studies Mark J. C. Nuijten Original Research Article 22 September 2012 Pages: 33 - 41
Economic Analysis of Carboplatin Versus Cisplatin in Lung and Ovarian Cancer Zeba M. KhanKaren L. RascatiJim M. Koeller Original Research Article 22 September 2012 Pages: 43 - 57
Cost of Illness and Disease Severity in a Cohort of French Patients with Parkinson’s Disease Claude LePenSuzanne WaitMarc Ziégler Original Research Article 22 September 2012 Pages: 59 - 69
Incremental Cost-Effectiveness Analysis of Intravenous Ganciclovir Versus Oral Ganciclovir in the Maintenance Treatment of Newly Diagnosed Cytomegalovirus Retinitis in Patients with AIDS Anita RachlisFiona SmaillAmy Jones Original Research Article 22 September 2012 Pages: 71 - 84
Diclofenac/Misoprostol Greg L. PloskerHarriet M. Lamb Adis Formulary Perspective 22 September 2012 Pages: 85 - 98
Donepezil Rachel H. FosterGreg L. Plosker Adis Formulary Perspective 22 September 2012 Pages: 99 - 114